CA2471601A1 - Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate - Google Patents
Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate Download PDFInfo
- Publication number
- CA2471601A1 CA2471601A1 CA002471601A CA2471601A CA2471601A1 CA 2471601 A1 CA2471601 A1 CA 2471601A1 CA 002471601 A CA002471601 A CA 002471601A CA 2471601 A CA2471601 A CA 2471601A CA 2471601 A1 CA2471601 A1 CA 2471601A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- biological material
- difluoro
- difmup
- protein tyrosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10200173.1 | 2002-01-04 | ||
DE2002100173 DE10200173A1 (de) | 2002-01-04 | 2002-01-04 | Ein hochsensitiver und kontinuerlicher Protein Tyrosin-Phosphatase (PTPase) Test unter Verwendung von 6,8 Difluoro-4-methyl-umbelliferylphosphat (DiFMUP) |
DE2002136329 DE10236329A1 (de) | 2002-08-08 | 2002-08-08 | Ein hochsensitiver und kontinuierlicher Protein Tyrosin-Phosphatase (PTPase) Test unter Verwendung von 6,8 Difluoro-4-methyl-umbelliferylphosphat (DiFMUP) |
DE10236329.3 | 2002-08-08 | ||
PCT/EP2002/014755 WO2003056029A2 (de) | 2002-01-04 | 2002-12-24 | EIN HOCHSENSITIVER UND KONTINUIERLICHER PROTEIN-TYROSIN-PHOSPHATASE (PTPase) TEST UNTER VERWENDUNG VON 6,8 DIFLUORO-4-METHYL-UMBELLIFERYLPHOSPHAT (DiFMUP) |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2471601A1 true CA2471601A1 (en) | 2003-07-10 |
Family
ID=26010898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002471601A Abandoned CA2471601A1 (en) | 2002-01-04 | 2002-12-24 | Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1466009A2 (de) |
JP (1) | JP2005512600A (de) |
KR (1) | KR20040073539A (de) |
CN (1) | CN1612939A (de) |
AU (1) | AU2002361217A1 (de) |
BR (1) | BR0215452A (de) |
CA (1) | CA2471601A1 (de) |
IL (1) | IL162832A0 (de) |
MX (1) | MXPA04006361A (de) |
NO (1) | NO20043244L (de) |
RU (1) | RU2004123794A (de) |
WO (1) | WO2003056029A2 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8278086B2 (en) | 2007-01-25 | 2012-10-02 | Roche Diagnostics Operations, Inc. | Enhancement of vanadium-containing phosphatase inhibitors |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100350045C (zh) * | 2003-08-21 | 2007-11-21 | 北京农业生物技术研究中心 | 玉米酪氨酸蛋白磷酸酶基因及其编码蛋白与应用 |
EP1949894B1 (de) * | 2007-01-25 | 2016-06-29 | Roche Diagnostics GmbH | Verstärkung von vanadiumhaltigen Phosphatasehemmern mit Polyole |
CN113155787A (zh) * | 2020-12-29 | 2021-07-23 | 武汉合研生物医药科技有限公司 | 一种突变酶shp2 e76k的活性检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214877B1 (en) * | 1998-05-12 | 2001-04-10 | John A. Butera | 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
-
2002
- 2002-12-24 IL IL16283202A patent/IL162832A0/xx unknown
- 2002-12-24 RU RU2004123794/15A patent/RU2004123794A/ru not_active Application Discontinuation
- 2002-12-24 WO PCT/EP2002/014755 patent/WO2003056029A2/de not_active Application Discontinuation
- 2002-12-24 KR KR10-2004-7010451A patent/KR20040073539A/ko not_active Application Discontinuation
- 2002-12-24 AU AU2002361217A patent/AU2002361217A1/en not_active Abandoned
- 2002-12-24 BR BR0215452-8A patent/BR0215452A/pt not_active Application Discontinuation
- 2002-12-24 CA CA002471601A patent/CA2471601A1/en not_active Abandoned
- 2002-12-24 JP JP2003556546A patent/JP2005512600A/ja not_active Withdrawn
- 2002-12-24 MX MXPA04006361A patent/MXPA04006361A/es not_active Application Discontinuation
- 2002-12-24 CN CNA028266668A patent/CN1612939A/zh active Pending
- 2002-12-24 EP EP02796734A patent/EP1466009A2/de not_active Withdrawn
-
2004
- 2004-08-02 NO NO20043244A patent/NO20043244L/no not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8278086B2 (en) | 2007-01-25 | 2012-10-02 | Roche Diagnostics Operations, Inc. | Enhancement of vanadium-containing phosphatase inhibitors |
US8563263B2 (en) | 2007-01-25 | 2013-10-22 | Roche Diagnostics Operations Inc. | Enhancement of vanadium-containing phosphatase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
MXPA04006361A (es) | 2004-10-04 |
EP1466009A2 (de) | 2004-10-13 |
BR0215452A (pt) | 2004-11-23 |
WO2003056029A3 (de) | 2004-04-01 |
IL162832A0 (en) | 2005-11-20 |
RU2004123794A (ru) | 2005-04-20 |
AU2002361217A1 (en) | 2003-07-15 |
KR20040073539A (ko) | 2004-08-19 |
JP2005512600A (ja) | 2005-05-12 |
NO20043244L (no) | 2004-08-02 |
CN1612939A (zh) | 2005-05-04 |
WO2003056029A2 (de) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang | Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis | |
Ángel Sentandreu et al. | A fluorescence-based protocol for quantifying angiotensin-converting enzyme activity | |
Wang et al. | An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-Ay mice | |
Walter et al. | Alkaline phosphatase in serum: continuous assay | |
JPH0642839B2 (ja) | 体液中のカリウムイオンを測定する方法及びそのための組成物 | |
CA1139201A (en) | Reagent for the determination of lipase and process for the preparation thereof | |
US20140273050A1 (en) | Methods of measuring cell viability in tissue engineered products | |
JPH0698032B2 (ja) | クレアチンもしくはクレアチニンの測定法及びこれらの測定用試薬 | |
US20030180827A1 (en) | Highly sensitive and continuous protein tyrosine phosphatase test using 6,8-difluoro-4-methylumbelliferyl phosphate | |
CA2471601A1 (en) | Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate | |
Falugi et al. | Cholinesterase activity and effects of its inhibition by neurotoxic drugs in Dictyostelium discoideum | |
Zimmerman | A rapid assay for pectinesterase activity which can be used as a prescreen for pectinesterase inhibitors | |
ZA200404694B (en) | Highly sensitive and continous protein-tyrosine-phosphatase (ptpase) test using 6,8 diflouro-4-methyl-umbelliferylphosphate. | |
Krishnamurthy et al. | Profiling protein tyrosine phosphatase activity with mechanistic probes | |
JPH1014596A (ja) | 体液中の成分の測定法およびその試薬 | |
US20050004068A1 (en) | Modulation of tor | |
Cromlish et al. | Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses | |
WO1993013219A1 (en) | Calcium ion determining composition | |
Kondrashin et al. | Cyclic adenosine 3 ‘: 5 ‘-Monophosphate-Dependent protein kinase on the external surface of LS-174T human Colon carcinoma cells | |
Osawa et al. | Development and application of serum cholinesterase activity measurement using benzoylthiocholine iodide | |
Infusino et al. | Enzymes and Their Clinical Use | |
Nishikata et al. | Continuous assay of protein tyrosine phosphatases based on fluorescence resonance energy transfer | |
KR20230136425A (ko) | 혈당측정기를 이용한 미생물 독소 검출 방법 | |
Royer et al. | The metastasis suppressor protein Nme1 is a concentration-dependent modulator of Ca2+/Calmodulin-dependent protein kinase II | |
Leuthardt et al. | 1-Phosphofructoaldolase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |